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Abstract
Background: Lungs of cystic fibrosis (CF) patients are chronically infected with Pseudomonas aeruginosa. Increased 
airway constriction has been reported in CF patients but underplaying mechanisms have not been elucidated. Aim: to 
examine the effect of P. aeruginosa LPS on airway constriction in CF mice and the implication in this process of cytosolic 
phospholipase A2α (cPLA2α), an enzyme involved in arachidonic acid (AA) release.
Methods: Mice were instilled intra-nasally with LPS. Airway constriction was assessed using barometric 
plethysmograph. MIP-2, prostaglandin E2 (PGE2), leukotrienes and AA concentrations were measured in BALF using 
standard kits and gas chromatography.
Results: LPS induced enhanced airway constriction and AA release in BALF of CF compared to littermate mice. This 
was accompanied by increased levels of PGE2, but not those of leukotrienes. However, airway neutrophil influx and 
MIP-2 production remained similar in both mouse strains. The cPLA2α inhibitor arachidonyl trifluoro-methyl-ketone 
(ATK), but not aspirin which inhibit PGE2 synthesis, reduced LPS-induced airway constriction. LPS induced lower airway 
constriction and PGE2 production in cPLA2α -/- mice compared to corresponding littermates. Neither aspirin nor ATK 
interfered with LPS-induced airway neutrophil influx or MIP-2 production.
Conclusions: CF mice develop enhanced airway constriction through a cPLA2α-dependent mechanism. Airway 
inflammation is dissociated from airway constriction in this model. cPLA2α may represent a suitable target for 
therapeutic intervention in CF. Attenuation of airway constriction by cPLA2α inhibitors may help to ameliorate the 
clinical status of CF patients.
Introduction
C y s t i c  f i b r o s i s  ( C F )  i s  t h e  m o s t  c o m m o n  r e c e s s i v e l y
inherited disorder in Caucasian population (1 on 2500
births) [1,2]. This disease is due to mutations in the CF
transmembrane conductance regulator gene [CFTR]. The
protein product of CFTR is a chloride channel expressed
in epithelial cells where it regulates the luminal secretion
of chloride and water transport to keep the homeostasis
of mucillary clearance. Mutations of CFTR lead to dys-
function of chloride and sodium channels, and as a con-
sequence to airway mucus dehydration and
hypersecretion. This leads to airway obstruction, chronic
bacterial infection by Pseudomonas aeruginosa, and
inflammation, which result in a dramatic respiratory
insufficiency. These pulmonary complications are the
most leading cause of mortality in CF patients. In addi-
tion to these manifestations, increased airway constric-
tion was reported in CF patients. Airway constriction is a
common feature in CF patients that seems to be exacer-
bated with age, although the underlying mechanism is
not known [3]. Pioneer clinical studies revealed increased
levels of prostaglandins (PGs) and leukotrienes (LTs) in
broncho-alveolar lavage fluids (BALF) of CF patients [4].
PGs and LTs are metabolites of arachidonic acid (AA)
that is released by cytosolic phospholipase A2α (cPLA2α)
[5,6]. This enzyme has been shown to play a role in vari-
ous animal models of lung inflammatory diseases includ-
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ing induction of airway resistance in response to allergic
challenge [7,8].
Taken together these findings led us to postulate that P
aeruginosa  LPS induces airway constriction in CF
through an activation of AA metabolism. Since the dis-
covery of the gene responsible for CF disease, a number
of CFTR gene-targeted mouse models, such as CFTR -/-
mice [9], were generated to investigate the pathophysiol-
ogy of this disease. In the present study, we investigated
the effect of P. aeruginosa LPS on airway constriction
using CFTR -/- mice. Our results showed that LPS
induced exacerbated airway constriction in CFTR -/-
mice compared to littermate and that cPLA2α plays a key
role in this process. In addition, cPLA2α induced airway
constriction occurs independently from lung inflamma-
tion. The molecular mechanisms underlying airway con-
striction in CFTR -/- mice and their pathophysiological
relevance in CF are discussed.
Materials and methods
Animals and reagents
CFTR-null mice (C57BL/6J Cftrm1UNC), established by
gene targeting [9] were obtained from the "CDTA" UPS44
CNRS (Orleans, France). Wild type and mutant litter-
mates were fed together by the mother until 3-4 weeks of
age. CFTR-/- mice typically die shortly after weaning
from intestinal obstruction. In order to increase the sur-
vival of these mice, we used a commercial osmotic laxa-
tive (Movicol®) which was provided continuously in the
drinking water [10]. Both CFTR-/- and littermates mice
received Movicol. Experiments were performed on 8-9
week-old mice.
cPLA2α-null mice were established by gene targeting as
described previously [8]. Mice heterozygous for a
cPLA2α mutant allele with the genetic background of the
C57BL/Ola hybrid were mated. Animals were fed a stan-
dard laboratory diet and water ad libitum. Eight to 9
week-old mutant homozygous mice (cPLA2α -/-) and
their homozygous control littermates (cPLA2α +/+) were
used in this study. The protocol for animal studies were
reviewed and approved by the Institute Pasteur Animal
Care and Use committee in accordance with French and
European guideline.
According to the experiment of Penh measurement,
animals (both CFTR and cPLA2) were divided into 4
groups including saline/wild type, saline/knock-out, LPS/
wild type and LPS/knock-out (n ≥ 6 for each group). Air-
way constriction (Penh) was monitored before and after
LPS/saline instillation as detailed below. In separate
groups of mice as described above (n ≥ 6 for each group),
24 h after LPS/saline treatment, cells counts in broncho-
alveolar lavage fluids were determined, eicosanoid acid
and cytokine were also measured. In certain experiments,
total RNA was extracted from lungs of treated animals 24
h later.
LPS and drug instillation
Mice were slightly anesthetized with ether. Anesthetized
mice received intra-nasal instillation of 330 μg/kg of P.
aeruginosa LPS (serotype 10; Sigma, St. Louis, MO) or
equivalent volume of saline. In certain experiments, ATK
(20 mg/kg) or aspirin (50 mg/kg) was injected intra-peri-
toneally 1 h before LPS challenge. The dose and route of
administration of ATK and aspirin used in the present
study were adopted from previous reports [11,12].
Measurement of airway constriction
Airway constriction was assessed in conscious and freely
moving mice using whole-body barometric plethysmog-
raphy (Buxco Electronics, USA) according to the manu-
facturer's instructions and previous reports [9,13-15]. In
brief, each animal was placed in a main chamber and the
pressure difference between this and a reference chamber
was measured with a differential pressure transducer
connected to amplifier and recorded with BioSystem XA
analyzer software (Buxco Electronics, Birmingham, U.K.).
Airway constriction expressed as enhanced pause (Penh)
was calculated as follows: Penh = (Te - Tr)/Tr(PEP/PIP),
where Te is the expiratory time (seconds), Tr is the relax-
ation time (time of the pressure decay to 36% of total box
pressure at expiration), PEP is the peak expiratory pres-
sure (milliliters per second), and PIP is the peak inspira-
tory pressure (milliliters per second).
BALF and cell counts
Twenty-four hours after LPS or saline challenge, mice
were anesthetized with pentobarbital (i.p.) and the tra-
chea was incised and cannulated. BALF were collected
with saline (4 × 0.5 ml) and total cell counts were deter-
mined using a Coulter counter (Coulter-Electronics,
Margency, France) as well as a Diff-Quik staining (Baxter-
Dale, Dudingen, Germany) of cytospin slides for cell dif-
ferential counts. Results are expressed as the number of
various cell populations per ml.
Cytokine and eicosanoid assays
PGE2, LTB4 and cysteinyl-leukotrienes (LTC4/D4/E4)
concentrations were measured using enzyme immunoas-
say from Cayman Chemical Co (USA). The cytokine
MIP2 was measured with a Kit DuoSet ELISA (R&D Sys-
tems).
Analysis of free AA
BALF samples were extracted by a mixture of chloroform,
methanol and water (4:2:1, v/v) in the presence of 15 μg of
heptadecanoic acid (internal standard). After vortex and
centrifugation at 800 g for 5 min, the chloroform phase
was collected and dried under a nitrogen stream. Then,Wu et al. Respiratory Research 2010, 11:49
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fatty acids were methylated and quantified by gas chro-
matography-mass spectrometry with the use of a gas
chromatograph as previously reported [16].
RNA extraction and quantitative PCR
Twenty-four hours after LPS/saline challenge, mice were
sacrificed by intra-peritoneal injection of an overdose of
pentobarbital sodium (40 mg/Kg). The chest was opened
and lung perfusion with saline was performed through
the pulmonary artery to remove blood. Then, the lung
tissue was excised and rinsed in a lysis buffer (Qiagen,
Courtaboeuf, France). After homogenization using Fast-
Prep system (MP Biomedicals, Illkirch, France), total
RNA was extracted from lung homogenate using RNeasy
mini kit (Qiagen, Courtaboeuf, France) according to the
manufacturer's instructions. The mRNA level was deter-
mined using an ABI 7900 Real Time PCR detection sys-
tem (Applied Biosystems, Foster City, CA). In brief, the
quantitative PCR was performed in 10 μl reactions that
contained 1 μl of diluted cDNA, 300 nM each of forward
and reverse primer, and 1× SYBR Green PCR Master Mix
(Fisher scientific, Illkirch, France). Each sample was run
in triplicate for each gene and relative quantity (RQ) of
mRNA calculated based on the housekeeping gene
HPRT. The primer sequence and PCR annealing temper-
ature were shown in Table 1.
Statistical analysis
Data are expressed as means ± sem of at least 6 mice in
each group. Statistical analysis was performed using
either unpaired Student's t test or ANOVA test for multi-
ple groups using SPSS software and p value less than 0.05
is considered as significant.
Results
Enhanced airway constriction in LPS-treated CFTR -/- mice
We first investigated the effect of LPS (330 μg/Kg) on air-
way constriction in CFTR -/- and CFTR +/+ mice. This
dose of LPS has been shown previously to induce an opti-
mal airway inflammation [17]. The Penh was monitored,
which reflects bronchopulmonary resistance of mice and
has been described in Methods. Our results showed that
untreated CFTR -/- mice exhibit similar values of Penh
compared to littermate mice (Figure 1). However, instilla-
tion of LPS increased airway constriction, which
occurred at higher magnitude in CFTR -/- compared to
CFTR +/+ mice (Figure 1). We verified that anesthesia by
itself had no effect on the measurement of Penh (data not
shown).
Airway inflammation is not different in CFTR -/- versus CFTR 
+/+ mice
We next examined whether increased airway constriction
is related to changes in lung inflammatory status of CFTR
-/- vs CFTR +/+ mice. The levels of total cell and neutro-
phil count and MIP-2 concentrations in BALF were simi-
lar in both the mouse strains after saline challenge (Figure
2). All these parameters increased 24 h after LPS chal-
lenge but their levels remained comparable in both the
mouse strains (Figure 2).
Increased AA and PGE2 levels in BALF of CFTR -/- mice
Subsequent analysis revealed that CFTR -/- mice exhib-
ited higher levels of AA in BALF as compared to CFTR +/
+ mice following LPS instillation (Figure 3A). This was
accompanied by an enhanced production of PGE2 (Fig-
ure 3B), whereas the levels of LTB4 (Figure 3C) and
cysteinyl-leukotrienes (LTC4/D4/E4) were similar in
BALF of the two mouse strains (Figure 3D). This led us to
examine the pulmonary expression of COX-1 and COX-
2, two major enzymes involved in PGE2 synthesis. The
expression levels of COX-1 were similar in CFTR +/+ and
CFTR -/- mice in basal conditions and LPS had no effect
on these levels (Figure 4A). Although LPS challenge
induced an increased COX-2 expression in lung tissues of
CFTR-/- and CFTR +/+ mice, no significant differences
were observed between these mouse strains neither
before nor after LPS challenge (Figure 4B).
A role for cPLA2α in LPS-induced airway constriction in 
CFTR -/- mice
The findings depicted above suggested that either AA or
its metabolite PGE2 may mediate enhanced airway con-
striction in LPS-treated CFTR -/- mice. This led us to
investigate the implication of cPLA2α, the key enzyme of
AA release, in LPS-induced airway constriction in CFTR
-/- mice using cPLA2α inhibitor, ATK. It should be noted
that in these experiments, either in ATK- or in vehicle-
treated mice, the Penh values were higher to those in the
other experiments (Figure 5). This is likely due to the
effect of ethanol, the ATK vehicle as this solvent has been
shown to exacerbate airway constriction [18,19]. In spite
Table 1: The primer sequence and PCR annealing temperature of quantitative PCR.
gene Forward primer Reverse primer Annealing Tm (°C)
COX1 5'-gcttcgtgaacataaccg-3' 5'-ggatgccagtgatagagatg-3' 58
COX2 5'-gtgcctggtctgatgatg-3' 5'-aatgcggttctgatactgg-3' 58.4
HPRT 5'-caggccagactttgttggat-3' 5'-ttgcgctcatcttaggcttt-3' 58Wu et al. Respiratory Research 2010, 11:49
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Figure 1 Induction by LPS instillation of airway constriction in CFTR-/- mice. Mice were kept in whole-body plethysmography system to measure 
basal level of Penh for 40 min. Then, they were subjected to intranasal instillation of either LPS (330 μg/kg) or the same volume of saline. Penh was 
measured continuously for 4 h and data were collected every 10 seconds and expressed as means of every 3 min. A representative graph is shown in 
A. The means of Penh values at the interval periods between 200 to 300 min were presented in B. * p < 0.05 LPS-treated CFTR -/- vs LPS-treated CFTR 
+/+ mice; ** p < 0.01 LPS-treated vs saline-treated CFTR -/- mice. †† p < 0.01 LPS-treated vs saline-treated CFTR +/+ mice.Wu et al. Respiratory Research 2010, 11:49
http://respiratory-research.com/content/11/1/49
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Figure 2 Cell counts and MIP-2 levels in BALF. CFTR-/- mice and their corresponding littermates were challenged either with LPS (330 μg/Kg) or 
saline via intranasal instillation. Twenty-four hours later, BALF were collected and then total cells and neutrophil counts (A) and MIP-2 levels were de-
termined (B). * p < 0.05 LPS vs saline-treated CFTR+/+ mice; ** p < 0.01 LPS vs saline-treated mice; ns, no significant differences between LPS-treated 
CFTR -/- vs CFTR +/+ mice.Wu et al. Respiratory Research 2010, 11:49
http://respiratory-research.com/content/11/1/49
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Figure 3 AA, PGE2 and leukotrienes levels in BALF. Twenty-four hours after LPS instillation, BAL were performed and levels of AA (A), PGE2 (B), LTB4 
(C) and cysLTs (D) were determined. * p < 0.05 and ** p < 0.01, LPS- vs saline-treated mice; † p < 0.05 CFTR-/- vs CFTR +/+ mice. ns, no significant 
differences between LPS-treated CFTR -/- vs CFTR +/+ mice.Wu et al. Respiratory Research 2010, 11:49
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of ethanol effect the results showed that pretreatment of
mice with ATK markedly reduced LPS-induced airway
constriction compared to ethanol-treated mice (Figure 5).
We next examined the effect of LPS on airway constric-
tion using cPLA2α -/- mice. We first showed that PGE2
levels were lower in BALFs in LPS stimulated cPLA2α -/-
compared to cPLA2α +/+ mice (Figure 6A), suggesting a
major role of cPLA2α in PGE2 release in airways of LPS-
treated mice. The figure 6B and 6C shows that LPS
induced much lower airway constriction in cPLA2α -/-
compared to cPLA2α +/+ mice. We next examined the
r o l e  o f  P G E 2  i n  L P S - i n d u c e d  a i r w a y  c o n s t r i c t i o n  i n
CFTR -/- mice. Pretreatment of these mice with the dual
COX-1/2 inhibitor aspirin had no effect on LPS-induced
airway constriction (Figure 7). We verified that in our
experimental conditions aspirin reduced by 90 ± 5%
(mean ± sem, n = 6) PGE2 levels in BALFs of LPS-treated
mice.
We also studied whether the cPLA2α/COX pathway
play a role in LPS-induced neutrophil recruitment and
MIP-2 production. No significant differences were
observed between cPLA2α -/- and cPLA2α +/+ mice
(data not shown). This was supported by the fact that
instillation of ATK or aspirin had no effect on these
inflammatory parameters neither before nor after LPS
challenge (data not shown).
Discussion
W e report here that CFTR -/- mice develop an exacer-
b a t e d  a i rw a y  c o n s t r i c t i o n  i n  r e s p o n s e  t o  L P S  a s  c o m -
pared to their corresponding littermates, which is in
agreement with observations made in CF patients [3]. In
addition to exacerbated pulmonary inflammation, CF
patients manifest airway obstruction and wheezing [20]
and near 40-50% of these patients have airway constric-
tion. This led us to explore the mediators involved in the
induction of airway constriction in CFTR -/- mice. Our
studies suggest that cPLA2α, which catalyzes the key step
of AA release, plays a role in enhanced airway constric-
tion observed in CFTR -/- mice. Indeed, we found an
increased concentration of AA in BALF from CFTR -/- vs
CFTR +/+ mice. Our findings are in agreement with the
pioneer work of Uozumi et al. reporting that cPLA2α
plays a key role in increased airway resistance in response
to allergic challenge [8]. Concerning the mechanism by
which CFTR regulates cPLA2α, recent studies in our lab-
oratory suggested that cPLA2α activity is inhibited by
CFTR through a protein-protein interaction [[21],
unpublished data (Dif F, Wu YZ)]. The absence of CFTR
or its F508del mutation (known to promote CFTR degra-
dation) may increase cPLA2α activity by the removal of
the CFTR inhibitory effect.
In the present study both cPLA2α null mutation and
pharmacological inhibition by the cPLA2α inhibitor,
ATK, reduced LPS-induced airway constriction in CFTR
-/- mice. This identifies cPLA2α as a key factor in LPS-
induced airway constriction in CFTR -/- mice. However,
we cannot exclude the contribution of another PLA2,
iPLA2, to this process. Indeed, ATK has been shown to
interfere with iPLA2 activity [22,23].
Our findings that the COX metabolites of AA did not
contribute to LPS-induced airway constriction in CF ani-
mal model are in agreement with the previous studies of
Vincent et al [24] which showed that aspirin fails to inter-
fere with LPS-induced airway constriction in guinea pig.
Aspirin did not interfere with LPS-induced airway con-
striction in mice and blockade of COX-2 activity by the
specific inhibitor NS-398 only delayed this airway con-
striction [25]. In the present study we only investigated
PGE2 levels since other studies have shown an increased
production of various PGs including PGF1, PGF2α in
BALF of LPS-treated CFTR -/- mice compared to their
littermates [26]. Because aspirin is known to suppress the
production of all PGs produced either by COX-1 and
COX-2 pathways, we can conclude that PGs are not
Figure 4 COX mRNA levels in lung tissues after LPS stimulation. 
Twenty-four hours after LPS instillation, mice were sacrificed and total 
RNA was extracted from homogenates of perfused lung. COX1 (A) and 
COX2 (B) mRNA levels were determined by quantitative PCR and ex-
pressed as RQ. RQ: relative quantity normalized to HPRT mRNA; * p < 
0.05 LPS-treated vs saline-treated mice. ns, no significant differences 
between LPS-treated CFTR -/- vs CFTR +/+ mice.Wu et al. Respiratory Research 2010, 11:49
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Figure 5 Effect of ATK on airway constriction of CFTR-/- mice. Either ATK (20 mg/Kg) or its vehicle, ethanol, were administered intraperitoneally 
to CFTR-/- and CFTR +/+ mice and basal Penh levels were measured for 40 min. Then, LPS (330 μg/kg) or saline were instilled intranasally and Penh 
was monitored as described before. A representative graph is shown in A. The means of Penh values at the interval periods between 200 to 300 min 
were presented in B. * p < 0.05 ethanol-treated CFTR -/- vs CFTR +/+ mice; ** p < 0.01 ethanol vs ATK-treated LPS challenged CFTR +/+ mice; †† p < 
0.01 ethanol vs ATK-treated LPS challenged CFTR -/- mice.Wu et al. Respiratory Research 2010, 11:49
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involved in LPS-induced airway constriction in CFTR -/-
mice.
On the other hand, our findings suggest that 5-LOX, a
major LOX pathway of AA metabolism is unlikely to be
involved in LPS-induced airway constriction. Indeed, the
levels of LTB4 and cysteinyl-leukotrienes (LTC4/D4/E4),
the products of AA via LOX, are similar in CFTR-/- com-
pared to CFTR +/+ mice. However, we cannot exclude
that other LOX-dependent metabolites such as those of
12-LOX can play a role in airway constriction. Indeed, the
expression level of this LOX has been shown to increase
in bronchial tissues of CF patients [27].
Our studies suggest that increased PGE2 production in
CFTR -/- mice may result, at least in part, from the avail-
ability of higher concentrations of free AA. This is in
agreement with previous studies reporting that epithelial
cells from CF patients release more AA than control cells
and express higher levels of cPLA2α activity [28-30]. The
fact that CFTR -/- and CFTR +/+ mice produce compara-
ble levels of LTB4 and cysteinyl-leukotrienes is paradoxi-
cal given the enhanced production of free AA in BALF of
CFTR -/- mice. Although the reasons for this paradoxical
observation are still unclear, we suggest that a metabolic
deviation of AA in favor of COX pathways may occur in
lung tissues of CFTR -/- mice. This might be due to an
enhanced activity of COX enzymes in spite of similar
expression levels in lungs from CFTR -/- and CFTR +/+
mice. I t is also likely that the activity of PGE synthase
(PGES), which produces PGE2 from PGH2, may increase
in lungs of CFTR -/- mice. Thus, in addition to changes in
AA levels and cPLAa activity, an increased PGES activity
could be a possible interpretation of PGE2 elevation in
CFTR -/- mice.
Failure to detect changes in leukotriene levels in CFTR
-/- mice is also in disagreement with the previously
Figure 6 Effect of LPS on airway constriction and PGE2 level in 
cPLA2α -/- mice. PGE2 levels were determined 24 h after LPS or saline 
instillation (A). Basal Penh levels in both cPLA2α -/- and cPLA2α +/+ 
mice were measured for 40 min. Then, LPS (330 μg/kg) or saline were 
instilled intranasally and Penh was monitored as described before. A 
representative graph is shown in B. The means of Penh values at the in-
terval times between 200 to 300 min were presented in C. * p < 0.05 
and †† p < 0.01, LPS vs saline-treated mice; ** p < 0.01 and † p < 0.05, 
LPS-treated cPLA2α +/+ vs cPLA2α -/- mice; ns, no significant differenc-
es between LPS vs saline-treated CFTR -/- mice.
Figure 7 Effect of aspirin on airway constriction of CFTR-/- mice. 
Either aspirin (50 mg/Kg) or saline were injected intraperitoneally to 
CFTR-/- mice and basal Penh levels were measured for 40 min. Then, 
LPS (330 μg/kg) were introduced intranasally and Penh was monitored 
as described in the Methods. A representative graph is shown in A. The 
means of Penh values at the interval periods between 200 to 300 min 
were presented in B.Wu et al. Respiratory Research 2010, 11:49
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reported high LTB4 levels in BALF of CF patients com-
pared to healthy subjects [4]. This discrepancy might be
due to differences in the expression levels of LOX, COX
and PGES in CF patients compared to CF mice. Previous
findings [31] reported an exacerbated expression of
COX-2 in epithelial cells and nasal polyps from CF
patients as compared to the corresponding controls [31].
Whether this discrepancy is due to differences in animal
species or cell types involved in COX expression remains
to be investigated. It remains also unclear whether COX-
2 up-regulation observed in polyps from CF patients is a
direct consequence of CFTR mutation and/or a second-
ary consequence of airway inflammation and infection
inherent to CF disease.
Although the molecular mechanisms involved in
cPLA2α-induced airway constriction in LPS-challenged
mice are still unclear it is likely that airway smooth mus-
cle cells (SMC) may play a role in this process. In the
asthmatic airway, acute airway constriction is caused, in
part, by the enhanced presence of mediators released
from inflammatory cells that directly induce bronchoc-
onstriction and enhance bronchoconstrictor responses to
other agonists. Airway obstruction and airway constric-
tion in CF patients coincide with those seen in asthma
and suggest that airway SMC remodeling may contribute
to lung pathology in CF [32]. Recent studies reported that
accumulation and/or hypertrophy of airway SMCs con-
tribute to airway narrowing and airway constriction in
CF patients [32,33]. A previous study showed that brady-
kinin-induced contraction of airway SMC occurs, in part,
via a process involving a rise of [Ca2+] and enhanced
release of AA [34]. More recently, it has been shown that
the AA metabolite 20-HETE induces sustained contrac-
tion of isolated guinea pig airway SMC [35]. Interestingly,
a recent study demonstrated that CFTR is also expressed
in tracheal SMC and may contribute to bronchodilation
[36]. Thus, it is likely that enhanced airway constriction
in CFTR-/- mice might partially be due to the lack of
bronchodilation function of CFTR in tracheal SMC. On
the other hand, morphological analysis of the trachea and
airway functional studies showed the presence of dis-
rupted or incomplete cartilage rings in trachea of both
adult and newborn CFTR -/- and F508del mice [37].
Although the loss of tracheal cartilage may predispose to
collapse of the airways, the possible relationship between
congenital malformations in CF mice and airway con-
striction remain to be investigated.
Our studies showed that although LPS induces airway
constriction in CFTR-/- and cPLA2α +/+ mice at differ-
ent intensity as compared to CFTR+/+ cPLA2α -/- mice,
respectively, all mouse strains develop a similar extent of
lung inflammation in term of neutrophil influx and MIP-
2 production. This can be explained by the fact that
cPLA2α may not play a role in lung inflammation in LPS
challenged mice. It is also likely that PGE2 plays a role in
attenuating lung inflammation in CFTR -/- mice since
this prostaglandin is well known to exert an anti-inflam-
matory effect in lungs [38]. Thus, the enhanced produc-
tion of PGE2 in CFTR -/- mice may explain, at least in
part, why these mice do not exhibit exacerbated lung
inflammation. The fact that airway constriction occurs
independently from lung inflammation is in agreement
with previous reports. Indeed, Lefort et al. showed that
airway constriction occurs independently of pulmonary
neutrophil recruitment or TNFα synthesis [39]. A similar
report showed that increased airway constriction
induced by inhaled LPS in COX-1 -/- and COX-2 -/- mice
is dissociated from airway inflammation [15].
Conclusions
LPS induces exacerbated airway constriction in CFTR -/-
mice, which occurs through a cPLA2α-dependent mech-
anism and is dissociated from airway neutrophil influx
and MIP-2 production. cPLA2α may represent a suitable
new target for therapeutic intervention in CF.
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